NOTE: This is a Forecasted Opportunity.
Hemophilia, von Willebrand disease and other inherited bleeding disorders cause significant disease burden and reduced quality of life. The purpose of this NOFO is to collect and utilize surveillance data within the network of federally supported hemophilia treatment centers to inform policies and clinical practices. The NOFO will build upon the current surveillance infrastructure to characterize bleeding disorders, increase understanding of treatment practices and patterns, monitor inhibitors and other health complications, and identify causes of death among persons with bleeding disorders. The long-term outcomes are to reduce and prevent health complications and improve the quality of life of those living with bleeding disorders.
Estimated Post Date:
Mar 01, 2025
Estimated Application Due Date:
May 15, 2025
Sponsor Institute/Organizations: Centers for Disease Control and Prevention
Address: Centers for Disease Control and Prevention Office of Science Quality 1600 Clifton Road, NE Mail Stop D-72 Atlanta, Georgia 30333
May 15, 2025
Varies
Affiliation: Centers for Disease Control and Prevention
Address: Centers for Disease Control and Prevention Office of Science Quality 1600 Clifton Road, NE Mail Stop D-72 Atlanta, Georgia 30333
Website URL: https://www.zintellect.com/Opportunity/Details/CDC-NCCDPHP-DHDSP-2024-0148
Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.